Disease | hepatitis |
Phenotype | C0024314|lymphoproliferative disorder |
Sentences | 11 |
PubMedID- 24868264 | Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses. |
PubMedID- 24374940 | Mixed cryoglobulinemia is a lymphoproliferative disorder associated with hepatitis c virus (hcv). |
PubMedID- 21503909 | The aims of this cohort study were to evaluate the association of malignant lymphoproliferative disorders in patients with chronic viral hepatitis and to compare the results with those in individuals with non-alcoholic fatty liver disease. |
PubMedID- 20945824 | A high frequency of chronic lymphoproliferative disorders associated with hepatitis virus infections was found in women, especially over 50 years old. |
PubMedID- 22715204 | lymphoproliferative disorders associated with hepatitis c virus (hcv) make up a heterogeneous group of diseases, including lymphomas. |
PubMedID- 20981794 | Hcv infection of b cells is a predictive factor for lymphoproliferative disorders in patients with chronic hepatitis c, although its molecular mechanisms remain unknown. |
PubMedID- 23929267 | We describe a retrospective series of b-cell lymphoproliferative disorders associated with hepatitis c virus infection. |
PubMedID- 24879033 | Three different histological subtypes of epstein-barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis c infection. |
PubMedID- 25815218 | Mixed cryoglobulinemia (mc) is an autoimmune/b-cell lymphoproliferative disorder associated with hepatitis c virus (hcv) infection, manifesting as a systemic vasculitis. |
PubMedID- 22128078 | Patients with chronic inflammatory rheumatic disease (eg, ra, spondylarthropathy, psoriatic arthritis, gout, chondrocalcinosis or other autoimmune diseases) were excluded as well as underlying comorbidities, eg, uncontrolled diabetes, unstable ischaemic heart disease, congestive heart failure, active inflammatory bowel disease, recent stroke (within 3 months before screening), chronic leg ulcer, lymphoproliferative disorders, history of cancer, active hepatitis b or c infection, positive hiv status and persistent or recurrent infections requiring treatment with antibiotics within 30 days before enrolment. |
PubMedID- 22567048 | The patients were diagnosed with chronic lymphoproliferative disorders associated with hepatitis virus b/c/d infections. |
Page: 1